Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 9 Results

  1. 1
    374424

    Climate change: time to "think family planning." An advocacy toolkit for family planning advocates.

    International Planned Parenthood Federation [IPPF]; Population & Sustainability Network

    [London, United Kingdom, IPPF], 2016. 21 p.

    Family planning is a critical, human rights-based, and cost-effective approach to climate change adaptation and resilience building. The aims of the paper are for national family planning advocates to be better placed to ensure: (a) national development (including climate change) planning processes include greater emphasis on family planning; and (b) more “climate change programmes” include family planning actions, therefore increasing overall investment and action in reproductive health. After defining “climate change” and introducing the United Nations Framework Convention on Climate Change, 10 arguments are summarised which national family planning advocates are encouraged to employ, to suit their national contexts, to further these aims.
    Add to my documents.
  2. 2
    374423

    Climate change: time to "think family planning." A communications toolkit for family planning advocates.

    International Planned Parenthood Federation [IPPF]; Population & Sustainability Network

    [London, United Kingdom, IPPF], 2016. 9 p.

    This paper asserts that family planning is a critical, human rights-based, and cost-effective approach to climate change adaptation and resilience building. The aims of the paper are for national family planning advocates to be better placed to ensure: (a) national development plans (including climate change planning processes) include greater emphasis on voluntary family planning; and (b) more “climate change programmes” and strategies include family planning actions, therefore increasing overall investment and action in reproductive health. The accompanying policy paper summarises strategies which family planning advocates are encouraged to employ, to suit their national contexts, to further these aims. This Communications Toolkit summarises how those arguments can be edited into key messages and how those key messages can be used to reach advocacy targets in the run up to COP22, the next Climate Change Conference, to be held in Marrakech, Morocco, from 7 to 18 November 2016.
    Add to my documents.
  3. 3
    375395

    A tool for strengthening gender-sensitive national HIV and Sexual and Reproductive Health (SRH) monitoring and evaluation systems.

    World Health Organization [WHO]; Joint United Nations Programme on HIV / AIDS [UNAIDS]

    Geneva, Switzerland, WHO, 2016. 126 p.

    WHO and UNAIDS have released a new tool for strengthening gender-sensitive national HIV and sexual and reproductive health (SRH) monitoring and evaluation systems. The tool provides step-by-step guidance to strategic information specialists and monitoring and evaluation officers of HIV and SRH programmes on how to ask the right questions in order to uncover gender inequalities and their influence on health; identify and select gender-sensitive indicators; conduct gender-analysis of SRH and HIV data; and strengthen monitoring and evaluation systems to enable appropriate data collection and gender analysis. The tool has been used by nearly 30 country teams of strategic information specialists, civil society and HIV programme implementers to analyse their own SRH and HIV data from a gender equality perspective. It can be used for training monitoring and evaluation specialists as well as a resource guide for SRH and HIV programmes to develop gender profiles of their SRH and HIV situation. “Know your epidemic, know your response” has been the cornerstone of the HIV response. This tool supports this approach by helping identify inequities and underlying drivers and hence, improve evidence-informed SRH and HIV programmes for all, but particularly for women and girls.
    Add to my documents.
  4. 4
    375328

    Guide to introducing HPV vaccine into national immunization programmes.

    World Health Organization [WHO]. Department of Immunization, Vaccines and Biologicals. Expanded Programme on Immunization [EPI]

    Geneva, Switzerland, WHO, EPI, 2016. 104 p.

    This document is intended for use by national immunization programme managers and immunization partners to inform the policy discussions and operational aspects for the introduction of HPV vaccine into national immunization programmes and to provide up-to-date references on the global policy, as well as the technical and strategic issues related to the introduction of HPV vaccine.
    Add to my documents.
  5. 5
    374002
    Peer Reviewed

    Development, updates, and future directions of the World Health Organization Selected Practice Recommendations for Contraceptive Use.

    Chen MJ; Kim CR; Whitehouse KC; Berry-Bibee E; Gaffield ME

    International Journal of Gynecology and Obstetrics. 2016 Dec 13; 7 p.

    Correct and consistent use of contraception decreases the risk of unintended pregnancy; yet, outdated policies or practices can delay initiation or hinder continuation of contraceptive methods. To promote the quality of, and access to, family planning services, WHO created a series of evidence-based guidance documents for family planning, known as WHO's Four Cornerstones of Family Planning Guidance. The Medical eligibility criteria for contraceptive use (MEC), first published in 1996, provides guidance on the safety of various contraceptive methods in users with specific health conditions or characteristics (i.e. who can use a contraceptive method safely). The Selected practice recommendations for contraceptive use (SPR) is the second cornerstone, outlining how to safely and effectively use contraceptive methods. These two documents can serve as a reference for policymakers and program managers as they develop their own national family planning policies in the context of local needs, values, and resources. The two other cornerstone documents -- the Decision making tool for family planning clients and providers and Family planning: a global handbook for providers -- provide guidance to healthcare providers for applying these recommendations in practice. Between 2013 and 2014, WHO convened a Guideline Development Group (GDG) to review and update the MEC and SPR in line with current evidence. As a result of these meetings, the fifth edition of the MEC was published in 2015, and the third edition of the SPR will be released on December 14, 2016. The purpose of the present report is to describe the methods used to develop the SPR recommendations, research gaps identified during the guideline development process, and future directions for the dissemination and implementation of the SPR among policymakers and family planning program managers worldwide. (excerpt)
    Add to my documents.
  6. 6
    375167

    WHO recommendations on antenatal care for a positive pregnancy experience.

    World Health Organization [WHO]. Department of Reproductive Health and Research; World Health Organization [WHO]. Department of Nutrition for Health and Development; World Health Organization [WHO]. Department of Maternal, Newborn, Child and Adolescent Health

    Geneva, Switzerland, WHO, 2016. 172 p.

    The World Health Organization has released a new set of antenatal care (ANC) recommendations to improve maternal and perinatal health worldwide. The guidelines seek to reduce the global burden of stillbirths, reduce pregnancy complications and provide all women and adolescents with a positive pregnancy experience. High quality health care during pregnancy and childbirth can prevent deaths from pregnancy complications, perinatal deaths and stillbirths, yet globally, less than two-thirds of women receive antenatal care at least four times throughout their pregnancy. The new ANC model raises the recommended number of ANC visits from four to eight, thereby increasing the number of opportunities providers have to detect and address preventable complications related to pregnancy and childbirth. The guidelines provide 49 recommendations for routine and context-specific ANC visits, including nutritional interventions, maternal / fetal assessments, preventive measures, interventions for common physiological symptoms and health system interventions. Given that women around the world experience maternal care in a wide range of settings, the recommendations also outline several context-specific service delivery options, including midwife-led care, group care and community-based interventions.
    Add to my documents.
  7. 7
    375003

    WHO guidelines for the treatment of Chlamydia trachomatis.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [56] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated treatment recommendations for common infections caused by C. trachomatis based on the most recent evidence; they form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols, adapting this guidance to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with C. trachomatis; and to support countries to update their national guidelines for treatment of chlamydial infection.
    Add to my documents.
  8. 8
    375002

    WHO guidelines for the treatment of Treponema pallidum (syphilis).

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [60] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated treatment recommendations for treatment of Treponema pallidum (syphilis) based on the most recent evidence. They form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols and adapt it to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with Treponema pallidum; and to support countries to update their national guidelines for treatment of Treponema pallidum.
    Add to my documents.
  9. 9
    375001

    WHO guidelines for the treatment of Neisseria gonorrhoeae.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [64] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update treatment recommendations for gonococcal infections to respond to changing antimicrobial resistance (AMR) patterns of N. gonorrhoeae. High-level resistance to previously recommended quinolones is widespread and decreased susceptibility to the extended-spectrum (third-generation) cephalosporins, another recommended first-line treatment in the 2003 guidelines, is increasing and several countries have reported treatment failures. These guidelines for the treatment of common infections caused by N. gonorrhoeae form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols, adapting this guidance to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with N. gonorrhoeae; and to support countries to update their national guidelines for treatment of gonococcal infection.
    Add to my documents.